News | Breast Density | March 24, 2016 | Jeff Zagoudis

State now requires notification for all patients, regardless of personal fibroglandular density levels

Indiana, breast density notification law, 2016

March 23, 2016 — Indiana Gov. Mike Pence signed an amendment to the state’s 2013 breast density reporting bill Wednesday expanding the requirements for notification. The amended law goes into effect July 1, 2016.

The state had previously enacted Senate Enrolled Act (SEA) 414 three years ago, which required notification in the mammography report if a patient was determined to have dense fibroglandular breast tissue. SEA 414 also required the provision of insurance coverage for supplemental screening for women at least 40 years old determined to have high breast density.

“We never considered it a density reporting bill as the wording stated that women would be notified about their dense tissue only if they needed further follow-up or testing,” said Nancy Cappello, Ph.D., director and founder of advocacy group Are You Dense of the existing legislation. “Density reporting should not be contingent on anything other than reporting the woman’s breast tissue composition.”

The new amendment, designated House Bill (HB) 1272, removes the specific language that only required notification if high breast density was determined. All mammography reports must now include information about fibroglandular breast density, regardless of whether or not the patient is determined to be fibroglandularly dense.

With the approval, Indiana becomes the 25th state to adopt a full breast density notification law. Three other states — New Hampshire, Vermont and Mississippi — have introduced bills in 2016, and a total of eight states are currently debating similar legislation.

For more information: www.areyoudenseadvocacy.org


Related Content

News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
Subscribe Now